JOURNAL ARTICLE
REVIEW
Add like
Add dislike
Add to saved papers

Future Research Directions for the Trophoblast Model of Cancer.

The trophoblast model of cancer is incorporated into The Gonzalez Protocol for treatment of cancer and a range of noncancer chronic diseases. The other main component of the Protocol involves the prescription of detailed diets and supplementation. The foundation of the diet and supplementation component of the Protocol is the theory of autonomic types, which range from parasympathetic-dominant, through balanced, to sympathetic-dominant; a person's autonomic type determines the details of the prescribed diet and supplements. The core anticancer component of the Protocol is pancreatic enzymes. Dr. Nicholas Gonzalez died in 2015; a research program studying the main components of The Gonzalez Protocol™ would contribute to his work being remembered and used by other practitioners. The author reviews the evidence base for the clinical effectiveness of The Gonzalez Protocol, which consists of Level II evidence, and outlines future research directions for the trophoblast model of cancer and the theory of autonomic types.

Full text links

We have located links that may give you full text access.
Can't access the paper?
Try logging in through your university/institutional subscription. For a smoother one-click institutional access experience, please use our mobile app.

Related Resources

For the best experience, use the Read mobile app

Mobile app image

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.

By using this service, you agree to our terms of use and privacy policy.

Your Privacy Choices Toggle icon

You can now claim free CME credits for this literature searchClaim now

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app